Evaluation of the effect of Pistacia atlantica oleoresin on clinical symptoms of the patients with Irritable bowel syndrome with constipation predominance

Babol University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新: 2022年1月11日

试验速览

暂无简介。

•The patient has not been treated with Pistacia atlantica oleoresin for the past month
•Patients with IBS whose type of disease has been confirmed by a complete medical examination.
•The patient signs a written consent
•Age over 18 years

•Pregnant or lactating women
•Patients with malignancies or other chronic gastrointestinal diseases such as inflammatory bowel disease and celiac disease
•History of major gastrointestinal surgery (including Billroth surgery, ostomy, and any resection in any part of the gastrointestinal tract).
•Inability to swallow capsules
•People taking psychotherapy drugs
•Patients at a serious health risk, including severe heart, liver or kidney disease
•Patients with severe plant allergies
•Regular use of drugs that change the movement of the gastrointestinal tract such as metoclopramide, cisapride, drugs, diphenoxylate, etc.
•Regular use of laxatives
•Follow the diet plans with daily and regular intake of prebiotic/probiotic compounds
•Taking antibiotics
•The patient has been treated with Pistacia atlantica for the past month
•Cigarette smoking, alcohol usage
•NSAID usage

发起方